Clinical Trial Update: Treatment of Allergic Rhinitis and Chronic Polypous Rhinosinusitis With Olfactory Mucosa-derived Mesenchymal Stem Cells [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial investigating olfactory mucosa-derived mesenchymal stem cells for allergic rhinitis and chronic rhinosinusitis with polyps; currently in Phase 1/…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Rhinosinusitis with Polyps

Drugs mentioned

• olfactory mucosa-derived mesenchymal stem cells

Snippet

Sponsor: Institute of Biophysics and Cell Engineering of National Academy of Sciences of Belarus | Conditions: Allergic Rhinitis, Rhinosinusitis Chronic | Phase 1, Phase 2 | Status: UNKNOWN